InvestorsHub.Com, Inc. – Trademark Portfolio
Entity Type: 03
InvestorsHub.Com, Inc. owns a portfolio of 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as IHUB, INVESTORSHUB, and INVESTORSHUB NEWSWIRE. Of these, 8 are registered. The portfolio spans 4 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 41 (Education & Entertainment). Headquartered in Tallahassee, FL.
3122 Mahan Dr., Ste 801-137
Tallahassee, FL 32308
Showing of trademarks Trademarks
Trademark Classifications
InvestorsHub.Com, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does InvestorsHub.Com, Inc. have?
InvestorsHub.Com, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 8 registered.
What trademark classes does InvestorsHub.Com, Inc. file in?
InvestorsHub.Com, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial), Class 38 (Telecommunications). Class 35 covers advertising; business management; business administration; office functions.
What are InvestorsHub.Com, Inc.'s most well-known trademarks?
InvestorsHub.Com, Inc.'s registered trademark portfolio includes well-known marks such as IHUB, INVESTORSHUB, and INVESTORSHUB NEWSWIRE. These are among 8 currently registered trademarks in the portfolio.
What is InvestorsHub.Com, Inc.'s trademark registration success rate?
InvestorsHub.Com, Inc. has a 100% trademark registration rate, with 8 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.